1 Delzenne, NM (2003) Oligosaccharides: state of the art. Proc Nutr Soc 62, 177–182.
2 Cani, PD, Dewever, C & Delzenne, NM (2004) Inulin-type fructans modulate gastrointestinal peptides involved in appetite regulation (glucagon-like peptide-1 and ghrelin) in rats. Br J Nutr 92, 521–526.
3 Cani, PD, Neyrinck, AM, Maton, N, et al. (2005) Oligofructose promotes satiety in rats fed a high-fat diet: involvement of glucagon-like peptide-1. Obes Res 13, 1000–1007.
4 Maurer, AD, Eller, LK, Hallam, MC, et al. (2010) Consumption of diets high in prebiotic fiber or protein during growth influences the response to a high fat and sucrose diet in adulthood in rats. Nutr Metab (Lond) 7, 77.
5 Gevrey, JC, Malapel, M, Philippe, J, et al. (2004) Protein hydrolysates stimulate proglucagon gene transcription in intestinal endocrine cells via two elements related to cyclic AMP response element. Diabetologia 47, 926–936.
6 Cordier-Bussat, M, Bernard, C, Levenez, F, et al. (1998) Peptones stimulate both the secretion of the incretin hormone glucagon-like peptide 1 and the transcription of the proglucagon gene. Diabetes 47, 1038–1045.
7 Drucker, DJ (2002) Biological actions and therapeutic potential of the glucagon-like peptides. Gastroenterology 122, 531–544.
8 Parnell, JA & Reimer, RA (2009) Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults. Am J Clin Nutr 89, 1751–1759.
9 Cani, PD, Lecourt, E, Dewulf, EM, et al. (2009) Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal. Am J Clin Nutr 90, 1236–1243.
10 Urias-Silvas, JE, Cani, PD, Delmee, E, et al. (2008) Physiological effects of dietary fructans extracted from Agave tequilana Gto. and Dasylirion spp. Br J Nutr 99, 254–261.
11 Delmee, E, Cani, PD, Gual, G, et al. (2006) Relation between colonic proglucagon expression and metabolic response to oligofructose in high fat diet-fed mice. Life Sci 79, 1007–1013.
12 Delzenne, NM, Cani, PD, Daubioul, C, et al. (2005) Impact of inulin and oligofructose on gastrointestinal peptides. Br J Nutr 93, Suppl. 1, S157–S161.
13 Tappenden, KA, Drozdowski, LA, Thomson, AB, et al. (1998) Short-chain fatty acid-supplemented total parenteral nutrition alters intestinal structure, glucose transporter 2 (GLUT2) mRNA and protein, and proglucagon mRNA abundance in normal rats. Am J Clin Nutr 68, 118–125.
14 Yang, J, Brown, MS, Liang, G, et al. (2008) Identification of the acyltransferase that octanoylates ghrelin, an appetite-stimulating peptide hormone. Cell 132, 387–396.
15 Gutierrez, JA, Solenberg, PJ, Perkins, DR, et al. (2008) Ghrelin octanoylation mediated by an orphan lipid transferase. Proc Natl Acad Sci U S A 105, 6320–6325.
16 Wettergren, A, Schjoldager, B, Mortensen, PE, et al. (1993) Truncated GLP-1 (proglucagon 78-107-amide) inhibits gastric and pancreatic functions in man. Dig Dis Sci 38, 665–673.
17 Roberfroid, MB (1999) Caloric value of inulin and oligofructose. J Nutr 129, 1436S–1437S.
18 Daubioul, C, Rousseau, N, Demeure, R, et al. (2002) Dietary fructans, but not cellulose, decrease triglyceride accumulation in the liver of obese Zucker fa/fa rats. J Nutr 132, 967–973.
19 Savage, DC (1986) Gastrointestinal microflora in mammalian nutrition. Ann Rev Nutr 6, 155–178.
20 Cani, PD & Delzenne, NM (2009) Interplay between obesity and associated metabolic disorders: new insights into the gut microbiota. Curr Opin Pharmacol 9, 737–743.
21 Cani, PD, Possemiers, S, Van de Wiele, T, et al. (2009) Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58, 1091–1103.
22 Cani, PD, Bibiloni, R, Knauf, C, et al. (2008) Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57, 1470–1481.
23 Ley, RE, Turnbaugh, PJ, Klein, S, et al. (2006) Human gut microbes associated with obesity. Nature 444, 1022–1023.
24 Duncan, SH, Lobley, GE, Holtrop, G, et al. (2008) Human colonic microbiota associated with diet, obesity and weight loss. Int J Obes (Lond) 32, 1720–1724.
25 Zhang, H, DiBaise, JK, Zuccolo, A, et al. (2009) Human gut microbiota in obesity and after gastric bypass. Proc Natl Acad Sci U S A 106, 2365–2370.
26 Cani, PD, Neyrinck, AM, Fava, F, et al. (2007) Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 50, 2374–2383.
27 Backhed, F, Ding, H, Wang, T, et al. (2004) The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A 101, 15718–15723.
28 Koletsky, S (1975) Pathologic findings and laboratory data in a new strain of obese hypertensive rats. Am J Pathol 80, 129–142.
29 Parnell, JA & Reimer, RA (2008) Differential secretion of satiety hormones with progression of obesity in JCR:LA-corpulent rats. Obesity (Silver Spring) 16, 736–742.
30 Hatanaka, S, Kondoh, M, Kawarabayashi, K, et al. (1994) The measurement of gastric emptying in conscious rats by monitoring serial changes in serum acetaminophen level. J Pharmacol Toxicol Methods 31, 161–165.
31 Massimino, SP, McBurney, MI, Field, CJ, et al. (1998) Fermentable dietary fiber increases GLP-1 secretion and improves glucose homeostasis despite increased intestinal glucose transport capacity in healthy dogs. J Nutr 128, 1786–1793.
32 Reimer, RA, Maurer, AD, Lau, DC, et al. (2010) Long-term dietary restriction influences plasma ghrelin and GOAT mRNA level in rats. Physiol Behav 99, 605–610.
33 Livak, KJ & Schmittgen, TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2( − Delta Delta C(T)) method. Methods 25, 402–408.
34 Boyle, FG, Wrenn, JM, Marsh, BB, et al. (2008) Safety evaluation of oligofructose: 13 week rat study and in vitro mutagenicity. Food Chem Toxicol 46, 3132–3139.
35 Tappenden, KA, Thomson, AB, Wild, GE, et al. (1996) Short-chain fatty acids increase proglucagon and ornithine decarboxylase messenger RNAs after intestinal resection in rats. JPEN 20, 357–362.
36 Drozdowski, LA, Dixon, WT, McBurney, MI, et al. (2002) Short-chain fatty acids and total parenteral nutrition affect intestinal gene expression. JPEN 26, 145–150.
37 Reimer, RA & Russell, JC (2008) Glucose tolerance, lipids, and GLP-1 secretion in JCR:LA-cp rats fed a high protein fiber diet. Obesity (Silver Spring) 16, 40–46.
38 Scrocchi, LA, Brown, TJ, MaClusky, N, et al. (1996) Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene. Nat Med 2, 1254–1258.
39 Scrocchi, LA & Drucker, DJ (1998) Effects of aging and a high fat diet on body weight and glucose tolerance in glucagon-like peptide-1 receptor − / − mice. Endocrinology 139, 3127–3132.
40 English, PJ, Ghatei, MA, Malik, IA, et al. (2002) Food fails to suppress ghrelin levels in obese humans. J Clin Endocrinol Metab 87, 2984–2987.
41 Zwirska-Korczala, K, Konturek, SJ, Sodowski, M, et al. (2007) Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome. J Physiol Pharmacol 58, Suppl. 1, 13–35.
42 Kirchner, H, Gutierrez, JA, Solenberg, PJ, et al. (2009) GOAT links dietary lipids with the endocrine control of energy balance. Nat Med 15, 741–745.
43 Gahete, MD, Cordoba-Chacon, J, Salvatori, R, et al. (2010) Metabolic regulation of ghrelin O-acyl transferase (GOAT) expression in the mouse hypothalamus, pituitary, and stomach. Mol Cell Endocrinol 317, 154–160.
44 Gonzalez, CR, Vazquez, MJ, Lopez, M, et al. (2008) Influence of chronic undernutrition and leptin on GOAT mRNA levels in rat stomach mucosa. J Mol Endocrinol 41, 415–421.
45 Gallagher, TK, Geoghegan, JG, Baird, AW, et al. (2007) Implications of altered gastrointestinal motility in obesity. Obes Surg 17, 1399–1407.
46 Cardoso-Junior, A, Coelho, LG, Savassi-Rocha, PR, et al. (2007) Gastric emptying of solids and semi-solids in morbidly obese and non-obese subjects: an assessment using the 13C-octanoic acid and 13C-acetic acid breath tests. Obes Surg 17, 236–241.
47 Turnbaugh, PJ, Ley, RE, Mahowald, MA, et al. (2006) An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444, 1027–1031.
48 Backhed, F, Manchester, JK, Semenkovich, CF, et al. (2007) Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci U S A 104, 979–984.
49 Santacruz, A, Marcos, A, Warnberg, J, et al. (2009) Interplay between weight loss and gut microbiota composition in overweight adolescents. Obesity (Silver Spring) 17, 1906–1915.
50 Luoto, R, Kalliomaki, M, Laitinen, K, et al. (2010) The impact of perinatal probiotic intervention on the development of overweight and obesity: follow-up study from birth to 10 years. Int J Obes (Lond) 34, 1531–1537.
51 Kadooka, Y, Sato, M, Imaizumi, K, et al. (2010) Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial. Eur J Clin Nutr 64, 636–643.
52 Cani, PD, Amar, J, Iglesias, MA, et al. (2007) Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56, 1761–1772.
53 Aleixandre de Artiñano, A & Miguel Castro, M (2009) Experimental rat models to study the metabolic syndrome. Br J Nutr 102, 1246–1253.
54 Sampey, BP, Vanhoose, AM, Winfield, HM, et al. (2011) Cafeteria diet is a robust model of human metabolic syndrome with liver and adipose inflammation: comparison to high-fat diet. Obesity 19, 1109–1117.
55 Santacruz, A, Marcos, A, Warnberg, J, et al. (2009) Interplay between weight loss and gut microbiota composition in overweight adolescents. Obesity 17, 1906–1915.
56 Ley, RE, Turnbaugh, PJ, Klein, S, et al. (2006) Human gut microbes associated with obesity. Nature 444, 1022–1023.
57 Furet, J-P, Kong, L-C, Tap, J, et al. (2010) Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss. Diabetes 59, 3049–3057.
58 Beards, E, Tuohy, K & Gibson, G (2010) Bacterial, SCFA and gas profiles of a range of food ingredients following in vitro fermentation by human colonic microbiota. Anaerobe 16, 420–425.
59 Fleissner, CK, Huebel, N, Abd El-Bary, MM, et al. (2010) Absence of intestinal microbiota does not protect mice from diet-induced obesity. Br J Nutr 104, 919–929.
60 Amann, RI, Binder, BJ, Olson, RJ, et al. (1990) Combination of 16S rRNA-targeted oligonucleotide probes with flow cytometry for analyzing mixed microbial populations. Appl Environ Microbiol 56, 1919–1925.
61 Liu, WT, Mirzabekov, AD & Stahl, DA (2001) Optimization of an oligonucleotide microchip for microbial identification studies: a non-equilibrium dissociation approach. Environ Microbiol 3, 619–629.
62 Matsuki, T, Watanabe, K, Fujimoto, J, et al. (2004) Use of 16S rRNA gene-targeted group-specific primers for real-time PCR analysis of predominant bacteria in human feces. Appl Environ Microbiol 70, 7220–7228.
63 Franks, AH, Harmsen, HJ, Raangs, GC, et al. (1998) Variations of bacterial populations in human feces measured by fluorescent in situ hybridization with group-specific 16S rRNA-targeted oligonucleotide probes. Appl Environ Microbiol 64, 3336–3345.
64 Delroisse, JM, Boulvin, AL, Parmentier, I, et al. (2008) Quantification of Bifidobacterium spp. and Lactobacillus spp. in rat fecal samples by real-time PCR. Microbiol Res 163, 663–670.
65 Bernhard, AE & Field, KG (2000) Identification of nonpoint sources of fecal pollution in coastal waters by using host-specific 16S ribosomal DNA genetic markers from fecal anaerobes. Appl Environ Microbiol 66, 1587–1594.
66 Nadkarni, MA, Martin, FE, Jacques, NA, et al. (2002) Determination of bacterial load by real-time PCR using a broad-range (universal) probe and primers set. Microbiology 148, 257–266.
67 Bartosch, S, Fite, A, Macfarlane, GT, et al. (2004) Characterization of bacterial communities in feces from healthy elderly volunteers and hospitalized elderly patients by using real-time PCR and effects of antibiotic treatment on the fecal microbiota. Appl Environ Microbiol 70, 3575–3581.